Alnylam Pharmaceuticals, Inc. (ALNY)

Alnylam Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 25, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	32,420	30,350	24,021	29,238	20,282	15,100
Market Cap Growth	26.35%	26.35%	-17.84%	44.16%	34.32%	17.60%
Enterprise Value	32,319	30,296	24,278	29,564	19,873	14,639
Last Close Price	242.61	235.31	191.41	237.65	169.58	129.97
PS Ratio	13.77	13.50	13.14	28.18	24.02	30.64
PB Ratio	481.01	452.40	-108.87	-184.79	34.48	14.86
P/TBV Ratio	481.01	452.40	-	-	34.48	14.86
P/FCF Ratio	-	-	572.67	-	-	-
P/OCF Ratio	-	-	230.62	-	-	-
EV/Sales Ratio	14.38	13.48	13.28	28.50	23.54	29.70
EV/FCF Ratio	-	-	578.81	-	-	-
Debt / Equity Ratio	40.89	40.89	-12.16	-16.51	3.72	1.57
Debt / FCF Ratio	-	-	63.96	-	-	-
Asset Turnover	0.56	0.56	0.50	0.29	0.24	0.17
Inventory Turnover	3.86	3.86	2.85	1.57	1.74	1.19
Quick Ratio	2.61	2.61	2.86	3.17	3.79	4.23
Current Ratio	2.78	2.78	3.08	3.51	4.04	4.47
Return on Equity (ROE)	-	-	-	-526.14%	-106.31%	-69.92%
Return on Assets (ROA)	-2.74%	-2.74%	-4.78%	-13.65%	-12.56%	-17.85%
Return on Capital (ROIC)	-4.19%	-4.19%	-7.17%	-18.77%	-16.46%	-23.80%
Earnings Yield	-0.86%	-0.92%	-1.83%	-3.87%	-4.21%	-5.68%
FCF Yield	-0.13%	-0.14%	0.18%	-2.10%	-3.54%	-4.54%
Buyback Yield / Dilution	-2.20%	-2.20%	-2.64%	-2.73%	-3.01%	-5.24%

Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q